TITLE:
A Study in Children With Growth Failure Due to Chronic Renal Insufficiency (CRI) or End Stage Renal Disease (ESRD)

CONDITION:
Chronic Renal Insufficiency

INTERVENTION:
NONE

SUMMARY:

      This study is a multicenter, open-label, observational, postmarketing surveillance study
      that will collect information on the use of Genentech growth hormone (GH) preparations to
      treat children with CRI in the United States.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: N/A to 17 Years
Criteria:

        Inclusion Criteria:

          -  Children diagnosed with CRI or ESRD and treated with a Genentech GH preparation on or
             after 1 January 2001

          -  CRI documented using the Schwartz formula indicates a calculated creatinine clearance
             (CrCl) of <=75 mL/min/1.73 m^2

          -  Ability to keep follow up appointments throughout the study

        Exclusion Criteria:

          -  Subjects receiving a non-Genentech GH preparation

          -  Subjects with closed epiphyses

          -  Subjects with active neoplasia

          -  Current participation in another GH clinical study

          -  Current participation in the core study
      
